FDA puts NJ drug ingredients maker Spectrum through the wringer in scathing Form 483
Fierce Pharma
OCTOBER 11, 2023
With observations ranging from dirty packing rooms to incomplete lab control records, Spectrum Laboratory Products’ new FDA manufacturing write-up reads like a guide on what not to do when producin | With observations ranging from dirty packing rooms to incomplete lab control records, Spectrum Laboratory Products’ new FDA manufacturing write-up reads (..)
213 
Let's personalize your content